Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple SclerosisCarolina Rush, Mark S. Freedman, Harold Atkins|Cold Spring Harbor Perspectives in Medicine|2018Cited by 35
Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosisSimon Thebault, Mark S. Freedman, Marjorie A. Bowman et al.|Annals of Clinical and Translational Neurology|2020Cited by 34
A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosisGauruv Bose, Mark S. Freedman, Carolina Rush et al.|Multiple Sclerosis and Related Disorders|2021Cited by 30
Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspectiveGauruv Bose, Mark S. Freedman, Harold Atkins et al.|Multiple Sclerosis Journal|2020Cited by 14